Friday, December 6, 2019
wellness India Expo
Home Tags Trials

Tag: Trials

BD inaugurates Centre of Excellence in Clinical Flow Cytometry at AIMS,...

The new centre is aimed at increasing clinical research capabilities in India................

AstraZeneca set to expand its clinical research footprint in India

The establishment of a new Development Operations Centre by AstraZeneca at Bengaluru supports the development of innovative medicines and hosts clinical trial experts focused on core therapeutic areas................

Vyome Therapeutics begins phase 2 trial of its drug for acne...

The company has dosed the first patient in its Phase 2 trial of the Company’s lead clinical candidate, VB-1953, for the treatment of moderate to severe inflammatory acne vulgaris......................

Orthopedic prosthetics to get a facelift with successful research trials in...

In addition to the wide availability of technically advanced orthopedic prosthetics, escalating demand for custom-made orthopedic prosthetics is likely to push the growth of the global orthopedic prosthetics market in the next decade...................

ONCOCUR starts clinical assessment of nano-curcumin for oral cancer prevention

Pune based ONCOCUR has commenced the clinical study on nano-curcumin for oral cancer prevention at a leading hospital in Delhi NCR...........................

India gets its first-ever biofortified sorghum

This improved sorghum variety was developed by ICRISAT under HarvestPlus – sorghum biofortification project and was tested as PVK 1009 in Maharashtra state and in All India Co-ordinated Sorghum Improvement Project (AICSIP) trials...………..

Allogeneic stem cell therapy for peripheral artery disease raises hopes globally

Encouraging Phase II results were released in June 2018 for PLX-PAD, a placenta-based allogeneic stem cell therapy given intramuscularly, targeting peripheral artery disease (PAD)........................

“Need greater awareness on clinical research in India”

Mentioned Dr Chirag Trivedi, President, Indian Society for Clinical Research (ISCR) in an exclusive interaction with the BioVoice, where he shared his optimism on the turnaround for the clinical research sector that has been under distress since last half a decade...............

Novartis’ Scapho shows pioneering 4-year data in preventing Ankylosing Spondylitis progression

For the first time for any biologic, data show almost 80 percent of ankylosing spondylitis (AS) patients on Scapho have no radiographic progression of the spine at 4 years.......

Sanofi’s dengue vaccine might not work equally in all cases, reveals...

New analysis of long-term Dengvaxia data found differences in vaccine performance based on prior dengue infection. Company will ask regulators to update product label to reflect new information..........